pramipexole has been researched along with Daytime Sleepiness in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (78.57) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barone, P; Busse, M; Debieuvre, C; Fraessdorf, M; Hauser, RA; Mizuno, Y; Poewe, W; Rascol, O; Schapira, AH | 1 |
| Aarskog, D; Albrecht, S; Chaudhuri, KR; Ferini-Strambi, L; Partinen, M; Sohr, M; Verri, D | 1 |
| Atanasov, S; Castriotta, RJ; Kuna, ST; Lai, JM; Masel, BE; Wilde, MC | 1 |
| Abe, H; Baba, Y; Fukuyama, K; Higuchi, MA; Inoue, T; Uehara, Y; Yamada, T | 1 |
| Daghem, M; Grosset, DG; Grosset, KA; Macphee, GJ; Newman, EJ; Nissen, T; Odin, P; Pal, G; Stewart, M | 1 |
| Crevenna, R; Homann, CN; Ivanic, G; Ott, E; Suppan, K; Wenzel, K | 1 |
| Lang, AE; Razmy, A; Shapiro, CM | 1 |
| Guilleminault, C; Martinez, S | 1 |
| Köster, J; Möller, JC; Oertel, WH; Pezzoli, G; Provinciali, L | 1 |
| Attarian, HP; Black, DN; Quick, AD | 1 |
| Biglan, KM; Holloway, RG; McDermott, MP; Richard, IH | 1 |
| Agapito, C; Bhattacharya, KF; Chaudhuri, KR; Pal, S | 1 |
| Montastruc, JL; Rascol, O | 1 |
| Etminan, M; Rochon, PA; Samii, A; Takkouche, B | 1 |
2 review(s) available for pramipexole and Daytime Sleepiness
| Article | Year |
|---|---|
Sleep attacks--facts and fiction: a critical review.
Topics: Antiparkinson Agents; Benzothiazoles; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles | 2003 |
Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials.
Topics: Antiparkinson Agents; Benzothiazoles; Disorders of Excessive Somnolence; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; MEDLINE; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Risk Factors; Thiazoles | 2001 |
6 trial(s) available for pramipexole and Daytime Sleepiness
| Article | Year |
|---|---|
Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Disorders of Excessive Somnolence; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Severity of Illness Index; Time Factors | 2014 |
Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Benzothiazoles; Demography; Disorders of Excessive Somnolence; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Pramipexole; Prevalence; Restless Legs Syndrome; Severity of Illness Index | 2008 |
Treatment of sleep disorders after traumatic brain injury.
Topics: Adult; Benzhydryl Compounds; Benzothiazoles; Brain Injuries; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Dopamine Agonists; Female; Humans; Male; Modafinil; Narcolepsy; Nocturnal Myoclonus Syndrome; Pramipexole; Prospective Studies; Quality of Life; Sleep Apnea, Obstructive; Sleep Wake Disorders | 2009 |
Effect of chronic kidney disease on excessive daytime sleepiness in Parkinson disease.
Topics: Aged; Benzothiazoles; Comorbidity; Disorders of Excessive Somnolence; Dopamine Agonists; Female; Humans; Indoles; Kidney Diseases; Male; Middle Aged; Parkinson Disease; Pramipexole | 2011 |
Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Demography; Depression; Disorders of Excessive Somnolence; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Parkinson Disease; Pramipexole; Severity of Illness Index; Thiazoles; Tremor | 2005 |
Risk factors for somnolence, edema, and hallucinations in early Parkinson disease.
Topics: Adult; Age Distribution; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cohort Studies; Comorbidity; Disorders of Excessive Somnolence; Double-Blind Method; Edema; Female; Hallucinations; Heart Diseases; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Risk Factors; Sex Distribution | 2007 |
6 other study(ies) available for pramipexole and Daytime Sleepiness
| Article | Year |
|---|---|
Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Confidence Intervals; Disorders of Excessive Somnolence; Disruptive, Impulse Control, and Conduct Disorders; Dizziness; Dopamine Agonists; Drug Therapy, Combination; Female; Hallucinations; Humans; Indoles; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Time Factors | 2012 |
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
Topics: Aged; Benzothiazoles; Bromocriptine; Disorders of Excessive Somnolence; Dopamine Agonists; Dose-Response Relationship, Drug; Ergot Alkaloids; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Polysomnography; Pramipexole; Prospective Studies; Sleep; Thiazoles; Wakefulness | 2004 |
Periodic leg movements in prepubertal children with sleep disturbance.
Topics: Benzothiazoles; Brain; Child; Child, Preschool; Comorbidity; Diagnosis, Differential; Disorders of Excessive Somnolence; Dopamine Agonists; Fatigue Syndrome, Chronic; Female; Follow-Up Studies; Humans; Infant; Male; Mental Disorders; Nocturnal Myoclonus Syndrome; Polysomnography; Pramipexole; Prevalence; Prospective Studies; Severity of Illness Index; Thiazoles | 2004 |
New-onset narcolepsy with cataplexy in a geriatric patient.
Topics: Age Factors; Aged; Benzothiazoles; Clomipramine; Disorders of Excessive Somnolence; Dopamine Agonists; Electroencephalography; Humans; Magnetic Resonance Imaging; Male; Narcolepsy; Polysomnography; Pramipexole; Restless Legs Syndrome; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Wakefulness | 2006 |
A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cabergoline; Disorders of Excessive Somnolence; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Retrospective Studies; Thiazoles | 2001 |
Modafinil and pramipexole-associated somnolence.
Topics: Antiparkinson Agents; Benzhydryl Compounds; Benzothiazoles; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Dopamine Agonists; Humans; Modafinil; Parkinsonian Disorders; Pramipexole; Thiazoles; Treatment Outcome | 2001 |